Clinical Trial

Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients

Name: Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients — clinical trial record (NCT06350825)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

To evaluate: The radiographic progression-free survival (rPFS) of metastatic hormone-sensitive prostate cancer (mHSPC) patients treated with androgen deprivation therapy (ADT) + second-generation antiandrogens±chemotherapy combined with cytoreductive prostatectomy (CRP)

Trial Details

NCT Number	NCT06350825
Lead Sponsor	The First Affiliated Hospital with Nanjing Medical University
Conditions	Metastatic Prostate Cancer, Therapy, Directly Observed
Enrollment	200 participants
Start Date	2016-01-01
Primary Completion	2027-12-31 (estimated)
Study Completion	2028-12-31 (estimated)
Updated on ClinicalTrials.gov	2024-04-05